House Panel OKs FDA User Fees Bill Despite Sticking Points
A key House subcommittee on Tuesday easily approved a bill to reauthorize the U.S. Food and Drug Administration's user fee programs, but leaders said the two sides still had issues to...To view the full article, register now.
Already a subscriber? Click here to view full article